Answers are grounded in this paper and cite their sources.
Article1 September 1966Light-chain DiseaseAn Abortive Variant of Multiple MyelomaRALPH C. WILLIAMS JR., M.D., RICHARD D. BRUNNING, M.D., FRANK A. WOLLHEIM, M.D.RALPH C. WILLIAMS JR., M.D.Search for more papers by this author, RICHARD D. BRUNNING, M.D.Search for more papers by this author, FRANK A. WOLLHEIM, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-3-471 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTwenty-one per cent of 110 myeloma patients studied showed relative hypogammaglobulinemia by ordinary electrophoresis. Nine of ten living patients showed marked elevations of free serum L-chains (see Table 1) predominantly of one major L-chain type. Myeloma patients with sharp serum M-components also showed free serum L-chains and in 11%, concentrations of the same order of magnitude as was the case in the hypogammaglobulinemic patients. Attempts to detect the presence of small quantities of whole 7S myeloma protein by Gm character, immunologic deficiency, or H-chain subgrouping of gamma globulin fractions of hypogammaglobulinemic sera were generally unsuccessful. Two of ten patients studied...References1. WALDENSTRÖM J: Monoclonal and polyclonal gammopathies and the biological system of gamma globulins. Progr. Allerg. 6: 320, 1962. MedlineGoogle Scholar2. HEREMANSLAURELLMÅRTENSSONHEREMANSLAURELLSJOQUISTWALDENSTRÖM JFAHLMCBJJ: Studies on "abnormal" serum globulins (M-components) in myeloma, macroglobulinemia and related diseases. Acta Med. Scand. 170 (suppl. 367): 1, 1961. MedlineGoogle Scholar3. OSSERMANTAKATSUKI EFK: Plasma cell myeloma: gamma globulin synthesis and structure. A review of biochemical and clinical data, with the description of a newly-recognized and related syndrome, "H-gamma-2-chain (Franklin's) disease." Medicine (Balt.) 42: 357, 1963. CrossrefMedlineGoogle Scholar4. LAURELL CB Mobilities of M-components in starch gel electrophoresis. Acta Med. Scand. (suppl. 367) 17: 17, 1961. Google Scholar5. ENGLEWOODSCASTILLOPERT RLKRGBJH: Starch gel electrophoresis of serum proteins and urinary proteins from patients with multiple myeloma, macroglobulinemia, and other forms of dysproteinemia. Demonstration of diversity and complexity of protein alterations in 72 cases. J. Lab. Clin. Med. 58: 1, 1961. MedlineGoogle Scholar6. VAERMANFUDENBERGJOHNSONMANDY JPHHLBWJ: Size heterogeneity of normal and pathological γ1A globulins (abstract). Fed. Proc. 23: 558, 1964. Google Scholar7. HEREMANSHEREMANSSCHULTER JFMHE: Isolation and description of a few properties of the β2A-globulin of human serum. Clin. Chim. Acta 4: 96, 1959. CrossrefMedlineGoogle Scholar8. CUMMINGSFRANKLIN NAEC: Atypical γ1A-globulin with the electrophoretic properties of an α2-globulin occurring in multiple myeloma. J. Lab. Clin. Med. 65: 8, 1965. MedlineGoogle Scholar9. GUTMANMOOREGUTMANMCCLELLANKABAT ABDHEBVEA: Fractionation of serum proteins in hyperproteinemia with special reference to multiple myeloma. J. Clin. Invest. 20: 765, 1941. CrossrefMedlineGoogle Scholar10. OLHAGENTHORELLWISING BBP: The endocellular nucleic acid distribution and plasma protein formation in myelomatosis. Scand. J. Clin. Lab. Invest. 1: 49, 1949. CrossrefMedlineGoogle Scholar11. SOULIER JP: Etude electrophoretique de 86 cas de proteinurie. Presse Med. 61: 49, 1953. MedlineGoogle Scholar12. SNAPPERTURNERMOSCOVITZ ILBHL: Multiple Myeloma. Grune & Stratton, New York, 1953. Google Scholar13. HARLEYKEMPABDULLAH BJTAAD: Multiple myelomatosis with large myeloma cells and normal plasma-proteins. Lancet 269: 527, 1955. CrossrefMedlineGoogle Scholar14. MORTONDEUTSCH JIHF: Demonstration of marked Bence-Jones proteinemia. Proc. Soc. Exp. Biol. Med. 93: 402, 1956. CrossrefMedlineGoogle Scholar15. GRABARFAUVERTBURTINHARTMAN PRPL: Etude sur les proteines du myelome. II. Analyse immunoelectrophoretique des serum 30 malades. Rev. Franc. Etud. Clin. Biol. 1: 175, 1956. MedlineGoogle Scholar16. DUBOIS J: Myelome multiple sans dysproteinemie ni proteinurie. Thèse Clermont-Ferrand, 1958. Google Scholar17. SERRECAZALJAFFIOL HPC: Plasmocytome multiple a forme osseuse pure sans dysprotidemie et sans proteinurie. Bull. Soc. Med. Hop. Paris 74: 191, 1958. MedlineGoogle Scholar18. SERREJAFFIOL HC: Les anomalies proteiques dans le myelome multiple. Les formes biologiques atypiques et l'origine desproteines myelomateuses. Presse Med. 91: 2044, 1958. Google Scholar19. GLENCHURZINNEMANHALL HHHWH: A review of fifty-one cases of multiple myeloma. Emphasis on pneumonia and other infections as complications. Arch. Intern. Med. (Chicago) 103: 173, 1959. CrossrefGoogle Scholar20. BURTIN P: Etude immuno-electrophoretique des proteins du myelome, in Analyse Immuno-electrophoretique, edited by GRABAR, P., BURTIN, P. Masson et Cie., Paris, 1960, p. 157. Google Scholar21. OSSERMANLAWLER EFD: Immunoelectrophoretic characterization of the serum and urinary proteins in plasma cell myeloma and Waldenström's macroglobulinemia. Ann. N. Y. Acad. Sci. 94: 93, 1961. CrossrefMedlineGoogle Scholar22. HEREMANSHEREMANS JM: Immuno-electrophoresis. Acta Med. Scand. (suppl.) 367: 27, 1961. Google Scholar23. LEVYHEITZ JGR: Le Myelome avec aggamglobulinemie. Strasbourg Med. 14: 213, 1963. MedlineGoogle Scholar24. BERRODLARRATSANDORSUREAU JJGB: A case of immunological identity between the micromolecule of the serum and the urinary Bence Jones protein of the same patient. Nature (London) 202: 407, 1964. CrossrefMedlineGoogle Scholar25. SOLOMONFAHEY AJL: Bence Jones proteinemia. Amer. J. Med. 37: 206, 1964. CrossrefMedlineGoogle Scholar26. CEPPELLINI R: Nomenclature for human immunoglobulins. Bull. WHO 30: 447, 1964. MedlineGoogle Scholar27. KUNKEL HG: Zone electrophoresis, in Methods of Biochemical Analysis. Interscience Publishers, Inc., New York, 1954, p. 41. CrossrefGoogle Scholar28. Trautman R: Operating and comparating procedures facilitating schlieren pattern analysis in analytical ultracentrifugation. J. Phys. Chem. 60: 1211, 1956. CrossrefGoogle Scholar29. EPSTEINTANGROSS WVMD: Blocked antigen sites on the L-chain of human gamma globulin. Nature (London) 202: 1175, 1964. CrossrefMedlineGoogle Scholar30. TANEPSTEIN MWV: A direct immunologic assay of human sera for Bence Jones proteins (L-chains). J. Lab. Clin. Med. 66: 344, 1965. MedlineGoogle Scholar31. LEVYSOBER HBHA: A simple chromatographic method for preparation of gamma globulin. Proc. Soc. Exp. Biol. Med. 103: 250, 1960. CrossrefMedlineGoogle Scholar32. HUNTLEY CC: Simple gel diffusion micro-method for gamma-globulin determination. Pediatrics 31: 123, 1963. MedlineGoogle Scholar33. OUDIN J: Specific precipitation in gels and its application to immunochemical analysis. Meth. Med. Res. 5: 335, 1952. MedlineGoogle Scholar34. SLATERWARDKUNKEL RJSMHG: Immunological relationships among the myeloma proteins. J. Exp. Med. 101: 85, 1955. CrossrefMedlineGoogle Scholar35. GRUBBLAURELL RAB: Hereditary serological human serum groups. Acta Path. Microbiol. Scand. 39: 390, 1956. CrossrefMedlineGoogle Scholar36. HARBOE M: A new hemagglutinating substance in the Gm system, anti-Gmb. Acta Path. Microbiol. Scand. 47: 191, 1959. CrossrefMedlineGoogle Scholar37. MÅRTENSSON L: On the relationships between the γ-globulin genes of the Gm system. A study of Gm gene products in sera, myeloma globulins, and specific antibodies with special reference to the gene Gmf. J. Exp. Med. 120: 1169, 1964. MedlineGoogle Scholar38. KUNKELALLENGREYMÅRTENSSONGRUBB HGJCHMLR: A relationship between the H-chain groups of 7S γ-globulin and the Gm system. Nature (London) 203: 413, 1964. CrossrefMedlineGoogle Scholar39. GREYKUNKEL HMHG: H-chain subgroups of myeloma proteins and normal 7S γ-globulin. J. Exp. Med. 120: 253, 1964. CrossrefMedlineGoogle Scholar40. TERRYFAHEY WDJL: Subclasses of human γ2-globulin based on differences in the heavy polypeptide chains. Science 146: 400, 1964. CrossrefMedlineGoogle Scholar41. TERRYFAHEYSTEINBERG WDJLAG: Gm and Inv factors in subclasses of human IgG. J. Exp. Med. 122: 1087, 1965. CrossrefMedlineGoogle Scholar42. WILLIAMS RC: Heterogeneity of L-chain sites on Bence Jones proteins reacting with anti-γ-globulin factors. Proc. Nat. Acad. Sci. 52: 60, 1964. CrossrefMedlineGoogle Scholar43. PUTNAM FW: Aberrations of protein metabolism in multiple myeloma interrelationships of abnormal serum globulins and Bence-Jones proteins. Phys. Rev. 37: 512, 1957. CrossrefMedlineGoogle Scholar44. EDELMANGALLY GMJA: The nature of Bence Jones proteins. Chemical similarities to polypeptide chains of myeloma globulins and normal γ-globulins. J. Exp. Med. 116: 207, 1962. MedlineGoogle Scholar45. BERNIERPUTNAM GMFW: Polymerism, polymorphism, and impurities in Bence Jones proteins. Biochim. Biophys. Acta 86: 295, 1964. CrossrefMedlineGoogle Scholar46. MEYERPUTNAM FFW: The fate of injected Bence Jones protein. J. Exp. Med. 117: 573, 1963. CrossrefMedlineGoogle Scholar47. PUTNAMHARDY FWS: Proteins in multiple myeloma III origin of Bence-Jones protein. J. Biol. Chem. 212: 361, 1955. CrossrefMedlineGoogle Scholar48. SOLOMONWALDMANFAHEYMCFARLANE ATAJLAS: Metabolism of Bence Jones proteins. J. Clin. Invest. 43: 103, 1964. CrossrefMedlineGoogle Scholar49. EPSTEINTAN WVM: Bence Jones proteinemia associated with systemic lupus erythematosus (abstract). Arthritis Rheum. 7: 733, 1964. Google Scholar50. VAUGHANBARNETT JGEV: Increased production of circulating L-chains in acute serum sickness (abstract). Arthritis Rheum. 8: 476, 1965. Google Scholar51. ARMSTRONG JB: A study of renal function in patients with multiple myeloma. Amer. J. Med. Sci. 219: 488, 1950. CrossrefMedlineGoogle Scholar52. RUNDLESCOOPERWILLETT WWGRRW: Multiple myeloma IV abnormal serum components and Bence Jones protein. J. Clin. Invest. 30: 1125, 1951. CrossrefMedlineGoogle Scholar53. ACKERMANCARSONMALTBY LVCPJD: Plasma cell myeloma, a clinical, pathologic and roentgenogic review of 90 cases. Amer. J. Clin. Path. 25: 849, 1955. CrossrefMedlineGoogle Scholar54. KENNYMOLONEY JJWW: Multiple myeloma: diagnosis and management in a series of 57 cases. Ann. Intern. Med. 46: 1079, 1957. LinkGoogle Scholar55. JANSHEZDOMZ LMCA: Renal patterns in myeloma. Ann. Intern. Med. 52: 45, 1960. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Minneapolis, MinnesotaFrom the Arthritis Unit, Department of Medicine, and Department of Laboratory Medicine, University of Minnesota, Minneapolis, Minn.This study was supported in part by grant AM 07372, U. S. Public Health Service, Bethesda, Md., and by a grant from the Minnesota Arthritis Foundation.Requests for reprints should be addressed to Ralph C. Williams, Jr., M.D., Box 442, University Hospital, Minneapolis, Minn. 55455. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA novel approach for the chromatographic purification and peptide mass fingerprinting of urinary free light chainsDiagnosis and treatment of primary amyloidosisPathology of dysproteinemia: Light chain amyloidosis, non-amyloid immunoglobulin deposition disease, cryoglobulinemia syndromes, and macroglobulinemia of waldenströmDifferential Diagnosis of Monoclonal GammopathyLetters to the CaseMULTIPLE MYELOMA WITH RENAL FAILURE A CASE FOR INTENSIVE TREATMENTRenal lesions in dysproteinemiasSimple method for the screening of polymeric Bence Jones proteinsTreatment of multiple myelomaMultiple Myeloma: Current Concepts in Diagnosis and ManagementMyeloma with immunohistochemically different cell populations: Implication for the validity of immunohistochemical assessment of lymphoma cell monoclonalitySkeletal Scintigraphy with Technetium Diphosphonate in Multiple Myeloma-a Comparison with Skeletal X-RayMonoclonal Immunoglobulins As Biomarkers Of CancerLymphoplasmacytic myeloma. An immunological, immunohistochemical and electron microscopic studyParaplegia in Myelomatosis-A Study of 20 CasesBiology, Clinical Patterns, and Treatment of Multiple Myeloma and Related Plasma–Cell DyscrasiasImmunoglobulin Structure, Synthesis, Secretion, and Relation to Neoplasms of B CellsMultiple Myeloma with Massive Bence Jones Proteinuria and Preservation of Renal FunctionMonoclonal IgE with renal failureCase 18-1976Two cases of plasmacytoma in the oral cavityBence-Jones Proteins and Light Chains of ImmunoglobulinsImmunopathology of ImmunocytomasThe clinical spectrum of light chain myelomaMultiple Myeloma: A Clinical ReviewImmunologische und klinisch-chemische Untersuchungen bei GammopathienDie PlasmocytomniereIDIOPATHIC LIGHT CHAIN DYSCRASIA-A NEW DISTINCT ENTITY?Paraproteinämische HämoblastosenCharacterization of Proteinuria in Patients with Monoclonal Gammopathies through Sodium Dodecyl Sulphate—Polyacrylamide Gel ElectrophoresisPathophysiology of the Monoclonal GammopathiesCase 48-1972Structure and function of the kidney in multiple myelomaCreation of "Amyloid" Fibrils from Bence Jones Proteins in vitroLow Molecular Weight Serum Immunoglobulin M in Experimental TrypanosomiasisUrinary Immunoglobulins in Patients With CancerThe importance of immunochemical analyses in the differential diagnosis of microglobulinic myelomasMultiple myeloma with hypogammaglobulinemia.Electron microscopic and chromosome studiesAbnormal Proteinuria in Malignant DiseasesUse of Immunoelectrophoresis and Immunodiffusion in Clinical MedicinePARAPROTEIN PATTERNS IN AUSTRALIAImmunochemical Classes of Myelomatosis. INCLUDING DATA FROM A THERAPEUTIC TRIAL CONDUCTED BY A MEDICAL RESEARCH COUNCIL WORKING PARTYDefective (incomplete) synthesis of immunoglobulin heavy polypeptide chains as the cause of a myeloma-like diseaseImmunofluorescent studies of the myeloma kidney with special reference to light chain diseaseDetection of Bence Jones ProteinuriaStudies of Monoclonal Immunoglobulins (M-Components) in Various KindredsRALPH C. WILLIAMS JR., M.D., JEFFREY L. ERICKSON, B.A., HERBERT F. POLESKY, M.D., WILLIAM R. SWAIM, M.D.Die paraproteinämischen HämoblastosenGamma-globulins, antibodies, and myeloma proteins 1 September 1966Volume 65, Issue 3Page: 471-486KeywordsArthritisAttentionGlobulinsMedical servicesMyelomaProteinsResearch laboratories Issue Published: 1 September 1966 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Ralph C. Williams (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: